We have further characterized pulmonary infections by bronchoalveolar
lavage in hospitalized patients with cirrhosis. Sixty-seven consecutiv
e patients admitted to the Ohio State University Medical Center from 1
992 to 1995 with liver disease who underwent bronchoscopy with broncho
alveolar lavage were identified. Twenty-one patients with cirrhosis an
d pneumonia were further analyzed. During the same period, we consecut
ively identified 23 patients without liver disease or immunosupression
, 19 patients with HIV infections, and 30 patients with cancer or phar
macologic immunosuppression who had bronchoscopy with bronchoalveolar
lavage for pneumonia, These groups were included in these analyses as
a control and immunosuppressed controls, respectively. Bronchoscopy is
olated respiratory pathogens in 16 patients (76.2%) with cirrhosis and
6 patients (26.1%) in the control group (p = 0.002). Fungal organisms
were most commonly found in patients with cirrhosis although several
patients had more than one organism identified. The control group had
mostly bacterial pathogens; the immunosuppressed controls were commonl
y infected with opportunistic organisms. Six (85.7%) of 7 patients wit
h cirrhosis and fungal pneumonia died of their respiratory illness. Ho
spitalized patients with cirrhosis commonly have opportunistic pulmona
ry infections. diagnostic bronchoscopy and empiric antifungal therapy
should be considered in those who do not respond to antibiotics.